MARKET

MRUS

MRUS

Merus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.74
-0.22
-1.30%
Closed 16:00 02/27 EST
OPEN
16.80
PREV CLOSE
16.96
HIGH
17.13
LOW
16.36
VOLUME
17.68K
TURNOVER
--
52 WEEK HIGH
20.95
52 WEEK LOW
11.35
MARKET CAP
483.28M
P/E (TTM)
-13.2259
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MRUS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MRUS stock price target is 23.71 with a high estimate of 35.50 and a low estimate of 16.23.

EPS

MRUS News

More
  • ImmunoPrecise Subsidiary Joins Genmab and Merus in Expansion to new Biotech Accelerator at the Center of Europe's Most Competitive Science Region
  • CNW Group · 01/09 13:59
  • Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus
  • Benzinga · 12/29/2019 23:38
  • Merus: Catalyst Filled 2020 For Biclonics Platform, Concerns Remain
  • Seeking Alpha - Article · 12/20/2019 17:31
  • Merus's CEO to resign after 16 years
  • Seeking Alpha - Article · 12/16/2019 18:41

Industry

Biotechnology & Medical Research
-2.24%
Pharmaceuticals & Medical Research
-2.52%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About MRUS

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets expressed by T cells, as well as MCLA-145 that is designed to bind to a tumor-associated target with an immunomodulatory target involved in checkpoint inhibition.
More

Webull offers kinds of Merus NV stock information, including NASDAQ:MRUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRUS stock news, and many more online research tools to help you make informed decisions.